{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T13:16:19Z","timestamp":1770038179647,"version":"3.49.0"},"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T00:00:00Z","timestamp":1495756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/101649X\/1"],"award-info":[{"award-number":["BB\/101649X\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0177568","type":"journal-article","created":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T17:36:01Z","timestamp":1495820161000},"page":"e0177568","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["Pharmacokinetic\/pharmacodynamic integration and modelling of florfenicol for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida"],"prefix":"10.1371","volume":"12","author":[{"given":"Lucy","family":"Dorey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovic","family":"Pelligand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangrui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Lees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,5,26]]},"reference":[{"key":"ref1","first-page":"4619","article-title":"Pharmacokinetic\/pharmacodynamic (PK\/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization","volume":"55","author":"EI Nielsen","year":"2011"},{"key":"ref2","first-page":"2795","article-title":"Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic\/pharmacodynamic target","volume":"56","author":"MN Martinez","year":"2012"},{"key":"ref3","first-page":"1053","article-title":"Pharmacokinetic-Pharmacodynamic Modeling of Antibacterial Drugs","volume":"65","author":"EI Nielsen","year":"2013"},{"key":"ref4","first-page":"480","article-title":"Pharmacokinetic-Pharmacodynamic (PK-PD) modelling and the rational selection of dosage regimes for the prudent use of antimicrobial drugs","volume":"171","author":"MG Papich","year":"2014"},{"key":"ref5","first-page":"124","article-title":"Use of Monte Carlo simulation to determine pharmacodynamic cutoffs of amoxicillin to establish a breakpoint for antimicrobial susceptibility testing in pigs","volume":"75","author":"JF Rey","year":"2014"},{"key":"ref6","first-page":"542","article-title":"Pharmacokinetic\/pharmacodynamic evaluation of marbofloxacin in the treatment of <italic>Haemophilus parasuis<\/italic> and <italic>Actinobacillus pleuropneumoniae<\/italic> infections in nursery and fattener pigs using Monte Carlo simulations","volume":"37","author":"C Vilalta","year":"2014"},{"key":"ref7","first-page":"22","article-title":"Application of pharmacological principles to dosage design of antimicrobial drugs","volume":"8","author":"P Lees","year":"2015"},{"key":"ref8","unstructured":"CLSI. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals: Approved Standard\u2014Third Edition. 2004. In. CLSI document M31-A3."},{"key":"ref9","first-page":"1","article-title":"The role of PK\/PD parameters to avoid selection and increase of resistance: mutant prevention concentration","volume":"16","author":"JM Blondeau","year":"2004"},{"key":"ref10","first-page":"467","article-title":"Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine","volume":"27","author":"PL Toutain","year":"2004"},{"key":"ref11","article-title":"Standard PK\/PD concepts can be applied to determine a dosage regimen for a macrolide: the case of tulathromycin in the calf","author":"PL Toutain","year":"2016"},{"key":"ref12","first-page":"275","article-title":"Development and validation of a new model of inflammation in the cat and selection of surrogate endpoints for testing anti-inflammatory drugs","volume":"28","author":"JM Giraudel","year":"2005"},{"key":"ref13","first-page":"175","article-title":"PK-PD modelling: an alternative to dose titration studies for antimicrobial drug dosage selection","volume":"15","author":"P Lees","year":"2004"},{"key":"ref14","first-page":"26","article-title":"WS04 The population PK\/PD approach for a rational use of anti-infective drugs to minimize resistance","volume":"29","author":"PL Toutain","year":"2006"},{"key":"ref15","first-page":"457","article-title":"Pharmacokinetic\/pharmacodynamic integration and modelling of amoxicillin for the calf pathogens <italic>Mannheimia haemolytica<\/italic> and <italic>Pasteurella multocida<\/italic>","volume":"38","author":"P Lees","year":"2015"},{"key":"ref16","first-page":"65","article-title":"Activity of florfenicol for the porcine pneumonia pathogens <italic>Actinobacillus pleuropneumoniae<\/italic> and <italic>Pasteurella multocida<\/italic> using standardised verus non-standardised methodology","volume":"218","author":"L Dorey","year":"2016"},{"key":"ref17","first-page":"202","article-title":"Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: the VetPath study","volume":"172","author":"A de Jong","year":"2014"},{"key":"ref18","first-page":"340","article-title":"Pharmacodynamics of florfenicol for calf pneumonia pathogens","volume":"172","author":"J Illambas","year":"2013"},{"key":"ref19","first-page":"231","article-title":"Pharmacokinetic-pharmacodynamic integration and modelling of florfenicol in calves","volume":"37","author":"P Sidhu","year":"2014"},{"key":"ref20","first-page":"4712","article-title":"<italic>In Vitro<\/italic> Activity of Ceftaroline against Methicillin-Resistant <italic>Staphylococcus aureus<\/italic> and Heterogeneous Vancomycin-Intermediate <italic>S<\/italic>. <italic>aureus<\/italic> in a Hollow Fiber Model","volume":"53","author":"C Vidaillac","year":"2009"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0177568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:11:59Z","timestamp":1588965119000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0177568"}},"subtitle":[],"editor":[{"given":"Juan Manuel","family":"Serrano-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,26]]},"references-count":20,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0177568","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,26]]}}}